alanine has been researched along with Endometrial Neoplasms in 2 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Powell, MA | 1 |
| Sill, MW | 1 |
| Goodfellow, PJ | 1 |
| Benbrook, DM | 1 |
| Lankes, HA | 1 |
| Leslie, KK | 1 |
| Jeske, Y | 1 |
| Mannel, RS | 1 |
| Spillman, MA | 1 |
| Lee, PS | 1 |
| Hoffman, JS | 1 |
| McMeekin, DS | 1 |
| Pollock, PM | 1 |
| Paynter, RA | 1 |
| Hankinson, SE | 1 |
| Colditz, GA | 1 |
| Hunter, DJ | 1 |
| De Vivo, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open Label, Non-Randomized Multisite Phase II Trial Combining Bevacizumab, Atezolizumab and Rucaparib for the Treatment of Previously Treated Recurrent and Progressive Endometrial Carcinoma[NCT03694262] | Phase 2 | 30 participants (Actual) | Interventional | 2019-07-19 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for alanine and Endometrial Neoplasms
| Article | Year |
|---|---|
A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Disease-Free Survival; Endometrial Neoplasms; Female; Human | 2014 |
1 other study available for alanine and Endometrial Neoplasms
| Article | Year |
|---|---|
No evidence of a role for PPARgamma Pro12Ala polymorphism in endometrial cancer susceptibility.
Topics: Alanine; Alleles; Amino Acid Substitution; Androstenedione; Aromatase; Carcinoma; Case-Control Studi | 2004 |